Latest Breaking News On - Scleroderma trials - Page 1 : comparemela.com

The update to 2017 recommendations include targeted synthetic and biologic disease-modifying antirheumatic drugs for the first time.

Ariane herrickEuropean alliance of associationsEuropean congressUniversity of manchester englandBoehringer ingelheimEuropean allianceDel galdoLeeds teaching hospitalScleroderma trialsCrest syndromeBiologic therapyPulmonary hypertensionSystemic sclerosisDiffuse sclerodermaInterstitial lung diseaseHeart failure